RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21
Tae Jin Lee(Augusta University), Carlo M. Croce(The Ohio State University), Ji Young Yoo(The University of Texas MD Anderson Cancer Center), Matthew Old, Balveen Kaur(Augusta University), Ri Cui(Wenzhou Medical University), Peixuan Guo(The Ohio State University), Zhenghua Luo(The Ohio State University), Dan Shu(The Ohio State University), Alena Cristina Jaime‐Ramirez(The Ohio State University), Hui Li(Guiyang Medical University), Jianying Zhang(Shanxi Agricultural University), Hui-Lung Sun(The Ohio State University), Giulia Romano(Virginia Commonwealth University), Jun-Ge Yu(The Ohio State University Wexner Medical Center), Mario Acunzo(Libera Università Maria SS. Assunta)
Cited by 147
Related Papers
The role of MicroRNAs in human cancer
|Signal Transduction and Targeted Therapy|2016|2.5k
MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
|JAMA|2008|1.6k
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
|Proceedings of the National Academy of Sciences|2012|1.5k
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
|Proceedings of the National Academy of Sciences|2004|1.3k
MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior
|Journal of Clinical Oncology|2006|778